Strategy for regulating right heart function in LVAD patients
10.3760/cma.j.cn112434-20230723-00009
- VernacularTitle:左心室辅助装置植入患者右心功能调控策略
- Author:
Xiangnan FANG
1
;
Susu DONG
;
Hexin WANG
;
Jun LI
;
Hongwu WANG
Author Information
1. 天津大学泰达国际心血病医院麻醉科，天津 300457
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2024;40(2):124-128
- CountryChina
- Language:Chinese
-
Abstract:
End stage heart failure(ESHF) is the terminal stage of heart failure in patients with heart failure, or refractory heart failure. heart transplantation(HT) and mechanical circulatory assistance represented by ventricular assist device(VAD) are the main treatments for circulatory support in patients with ESHF. However, the serious shortage of donors has restricted the extensive development of HT. VAD technology, represented by left ventricular assist device(LVAD), has developed rapidly, and the 2-year survival rate after surgery has approached of HT. Although LVAD support can directly alleviate symptoms of left heart failure, it only partially relieves symptoms of right heart failure, resulting in high readmission rates.Therefore, more precise monitoring and regulation of right heart function in LVAD recipients is key to improving long-term prognosis. This article aims to provide an overview of strategies for the regulation of right heart function in patients after LVAD implantation.
